Status:

COMPLETED

Description of the Radiological Response of Anoperineal Fistulizing Lesions of Crohn's Disease

Lead Sponsor:

University Hospital, Rouen

Conditions:

Anoperineal Lesions

Crohn's Disease Relapse

Eligibility:

All Genders

18+ years

Brief Summary

The presence of ano-perineal lesions (APL) in Crohn's disease is common and represents a major burden for the patient. More than one-third of patients with Crohn's disease will develop at least one an...

Detailed Description

Currently, magnetic resonance imaging is the gold standard for diagnosing anoperineal lesions in Crohn's disease. It allows for precise mapping of lesions, and its safety allows for repeated use. MRI ...

Eligibility Criteria

Inclusion

  • All adult patients, monitored at the Rouen University Hospital for Crohn's disease, complicated by fistulizing anoperineal lesion, treated with Biotherapy, having benefited from an MRI at the start of treatment and during follow-up.

Exclusion

  • Minor patients
  • Patients with an anoperineal lesion, without Crohn's disease
  • Patients who have received surgical treatment with a stoma for perineal disease

Key Trial Info

Start Date :

July 31 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 31 2024

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT07152977

Start Date

July 31 2019

End Date

July 31 2024

Last Update

September 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Rouen Hospital

Rouen, France, 76031